Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 11, 2013 - Issue 12
Submit an article Journal homepage
198
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Systematic evaluation of non-inferiority and equivalence randomized trials of anti-infective drugs

Yunfei LiCenter for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China
,
Yingchun HeCenter for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China
,
Yucheng ShengCenter for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China
,
Kun WangCenter for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China
,
Jingjing WangCenter for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China
,
Jihan HuangCenter for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China
,
Juan YangCenter for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China
&
Qingshan ZhengCenter for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaCorrespondence[email protected]
 show all
Pages 1377-1389 | Published online: 10 Jan 2014

References

  • Christensen E. Methodology of superiority vs, equivalence trials and non-inferiority trials. J. Hepatol. 46(5), 947–954 (2007).
  • Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA 308(24), 2594–2604 (2012).
  • Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N. Engl. J. Med. 331(6), 394–398 (1994).
  • Simon R. Are placebo-controlled clinical trials ethical or needed when alternative treatment exists? Ann. Intern. Med. 133(6), 474–475 (2000).
  • Garattini S, Bertele V. Non-inferiority trials are unethical because they disregard patients’ interests. Lancet 370(9602), 1875–1877 (2007).
  • Chuang-Stein C, Beltangady M, Dunne M, Morrison B. The ethics of non-inferiority trials. Lancet 371(9616), 895–896, author reply 896–897 (2008).
  • Menten J, Boelaert M. The ethics of non-inferiority trials. Lancet 371(9616), 896, author reply 896–897 (2008).
  • Nunn AJ, Meredith SK, Spigelman MK, Ginsberg AM, Gillespie SH. The ethics of non-inferiority trials. Lancet 371(9616), 895, author reply 896–897 (2008).
  • Gandjour A. The ethics of non-inferiority trials. Lancet 371(9616), 895 (2008).
  • Soliman EZ. The ethics of non-inferiority trials. Lancet 371(9616), 895, author reply 896–897 (2008).
  • Piaggio G, Elbourne DR, Altman DG et al. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 295(10), 1152–1160 (2006).
  • Nduba VN, Mwachari CW, Magaret AS et al. Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial. Thorax 63(11), 999–1005 (2008).
  • Hazir T, Nisar YB, Abbasi S et al. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2–59 months: a multicenter, double-blind, randomized, placebo-controlled trial in Pakistan. Clin. Infect. Dis. 52(3), 293–300 (2011).
  • Awasthi S, Agarwal G, Kabra SK et al. Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial. PLoS ONE 3(4), e1991 (2008).
  • Duong M, Markwell S, Peter J, Barenkamp S. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann. Emerg. Med. 55(5), 401–407 (2010).
  • Autret-Leca E, Giraudeau B, Ployet MJ, Jonville-Bera AP. Amoxicillin/clavulanic acid is ineffective at preventing otitis media in children with presumed viral upper respiratory infection: a randomized, double-blind equivalence, placebo-controlled trial. Br. J. Clin. Pharmacol. 54(6), 652–656 (2002).
  • Shapiro RL, Thior I, Gilbert PB et al. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. AIDS 20(9), 1281–1288 (2006).
  • Saag M, Goodrich J, Fatkenheuer G et al. A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1. J. Infect. Dis. 199(11), 1638–1647 (2009).
  • Firnhaber C, Azzoni L, Foulkes AS et al. Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection. PLoS ONE 6(6), e21450 (2011).
  • Sterling TR, Villarino ME, Borisov AS et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N. Engl. J. Med. 365(23), 2155–2166 (2011).
  • Le Henanff A, Giraudeau B, Baron G, Ravaud P. Quality of reporting of noninferiority and equivalence randomized trials. JAMA 295(10), 1147–1151 (2006).
  • D’Agostino RB Sr, Massaro JM, Sullivan LM. Non-inferiority trials: design concepts and issues-the encounters of academic consultants in statistics. Stat. Med. 22(2), 169–186 (2003).
  • Fleming TR. Current issues in non-inferiority trials. Stat. Med. 27(3), 317–332 (2008).
  • Everson-Stewart S, Emerson SS. Bio-creep in non-inferiority clinical trials. Stat. Med. 29(27), 2769–2780 (2010).
  • Committee for Proprietary Medicinal Products. Points to consider on switching between superiority and non-inferiority. Br. J. Clin. Pharmacol. 52(3), 223–228 (2001).
  • Brittain E, Lin D. A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trials. Stat Med. 24(1), 1–10 (2005).
  • Abraha I, Montedori A. Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ 340, c2697 (2010).
  • Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA 309(8), 814–822 (2013).
  • Porcino AJ. The Greater Value of the CONSORT Statement Guidelines: Guideposts for Designing and Reporting all TMB Research. Int. J. Ther. Massage Bodywork 5(4), 1–2 (2012).
  • Powers JH. Noninferiority and equivalence trials: deciphering ‘similarity’ of medical interventions. Stat. Med. 27(3), 343–352 (2008).
  • Eyawo O, Lee CW, Rachlis B, Mills EJ. Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature. Trials 9, 69 (2008).
  • Lavender T, Furber C, Campbell M, et al. Effect on skin hydration of using baby wipes to clean the napkin area of newborn babies: assessor-blinded randomised controlled equivalence trial. BMC Pediatr. 12, 59 (2012).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.